Literature DB >> 12368226

CD99 isoforms expression dictates T cell functional outcomes.

Isabelle Alberti1, Ghislaine Bernard, Alexandre K Rouquette-Jazdanian, Claudette Pelassy, Monique Pourtein, Claude Aussel, Alain Bernard.   

Abstract

CD99, a unique integral membrane protein present on the surface of all human T cells, has previously been shown to regulate cell function and fate. In peripheral T cells, it triggers immediate activation of alpha4b1 integrin and cell arrest on inflamed vascular endothelium, whereas it mediates an apoptotic signal in double-positive thymocytes undergoing the selection process. Two isoforms of CD99 exist, a long form corresponding to the full-length protein and a short form harboring a deletion in the intracytoplasmic segment. Here, we show that while peripheral T cells display exclusive expression of the long form, double-positive thymocytes express both isoforms. Moreover, differential expression of these two CD99 molecules can lead to distinct functional outcomes. Expression of the long form in a CD99-deficient Jurkat T cell line is sufficient to promote CD99-induced cell adhesion, whereas coexpression of the two isoforms is required to trigger T-cell death. When coexpressed, the two proteins form covalent heterodimers, which locate within glycosphingolipidic rafts and induce sphingomyelin degradation. Cholesterol depletion experiments show that this localization is required for the induction of apoptosis. Thus, the surface expression pattern of CD99 isoforms determines T-cell functional outcomes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368226     DOI: 10.1096/fj.02-0049fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

1.  Neonatal hyperimmune T-cell reaction mimicking T-cell non-Hodgkin's lymphoma following BCG and hepatitis B co-vaccination.

Authors:  Snjezana Dotlic; Semir Vranic; Gordana Jakovljevic; Ivana Ilic; Mirjana M Kardum-Paro; Stefan D Dojcinov
Journal:  Virchows Arch       Date:  2012-09-12       Impact factor: 4.064

2.  CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage.

Authors:  Ursula Úrias; Suely K N Marie; Miyuki Uno; Roseli da Silva; Mariá M Evagelinellis; Otavia L Caballero; Brian J Stevenson; Wilson A Silva; Andrew J Simpson; Sueli M Oba-Shinjo
Journal:  J Neurooncol       Date:  2014-05-06       Impact factor: 4.130

3.  CD99 acts as an oncosuppressor in osteosarcoma.

Authors:  Maria Cristina Manara; Ghislaine Bernard; Pier-Luigi Lollini; Patrizia Nanni; Monia Zuntini; Lorena Landuzzi; Stefania Benini; Giovanna Lattanzi; Marika Sciandra; Massimo Serra; Mario Paolo Colombo; Alain Bernard; Piero Picci; Katia Scotlandi
Journal:  Mol Biol Cell       Date:  2006-01-18       Impact factor: 4.138

Review 4.  CD99 in malignant hematopoiesis.

Authors:  Atham Ali; Vijaya Pooja Vaikari; Houda Alachkar
Journal:  Exp Hematol       Date:  2021-12-14       Impact factor: 3.249

5.  Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma.

Authors:  Nuchjira Takheaw; Gunya Sittithumcharee; Ryusho Kariya; Watchara Kasinrerk; Seiji Okada
Journal:  Cancer Immunol Immunother       Date:  2020-11-19       Impact factor: 6.968

6.  CD99 is essential for leukocyte diapedesis in vivo.

Authors:  Eric M Dufour; Alana Deroche; Youngmee Bae; William A Muller
Journal:  Cell Commun Adhes       Date:  2008-11

7.  Expression of the peripheral benzodiazepine receptor triggers thymocyte differentiation.

Authors:  Pierrick Rochard; Sylvaine Galiegue; Norbert Tinel; Annick Peleraux; Annie Bord; Omar Jbilo; Pierre Casellas
Journal:  Gene Expr       Date:  2004

8.  Association of CD99 short and long forms with MHC class I, MHC class II and tetraspanin CD81 and recruitment into immunological synapses.

Authors:  Supansa Pata; Pavel Otáhal; Tomáš Brdička; Witida Laopajon; Kodchakorn Mahasongkram; Watchara Kasinrerk
Journal:  BMC Res Notes       Date:  2011-08-13

9.  CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling.

Authors:  S Ventura; D N T Aryee; F Felicetti; A De Feo; C Mancarella; M C Manara; P Picci; M P Colombo; H Kovar; A Carè; K Scotlandi
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

10.  CD99 ligation upregulates HSP70 on acute lymphoblastic leukemia cells and concomitantly increases NK cytotoxicity.

Authors:  Z Husak; M N Dworzak
Journal:  Cell Death Dis       Date:  2012-11-15       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.